✎ High patented drug prices impact public health; courts may intervene for affordability.
Relevance for Banking, SSC & RBI Grade B exams: Polity
The Kerala High Court has reserved its verdict in a suo motu case examining the exorbitant pricing of patented life-saving medicines, highlighting a critical issue in public health policy. The case originated from a patient’s plea seeking government intervention to compulsorily license or acquire the patent of Ribociclib, a breast cancer drug, to make it affordable. Though the petitioner passed away during the proceedings, the court took up the matter independently, emphasizing its significance for broader public interest. The court also permitted another breast cancer patient from Malappuram to join the case, underscoring the urgency of addressing high medication costs. This case raises pertinent questions about intellectual property rights, healthcare accessibility, and the role of the judiciary in balancing innovation incentives with public welfare, particularly in life-threatening conditions.
For banking and SSC aspirants, this case is relevant as it intersects with governance, policy-making, and constitutional provisions like Article 21 (Right to Life) and Article 39(b) (Directive Principles of State Policy). The debate over patented drug pricing also touches upon economic policies, fiscal responsibility, and the role of regulatory bodies like the Drug Controller General of India (DCGI). For RBI Grade B officers, understanding such socio-economic challenges is crucial, as they often influence monetary policy, inflation dynamics, and public expenditure priorities. The case exemplifies how judicial interventions can shape economic policies, making it a pertinent example for exams focusing on polity, governance, and current affairs.
Source: The Hindu
Generated by AanyaAi for educational purpose.
1 comment on “Kerala HC Reserves Verdict on Exorbitant Prices of Patent Life-Saving Drugs”